What is Theravance Biopharma's PP&E (net)?

Theravance Biopharma (TBPH) reported PP&E (net) of $5.54M in Q1 2026.

How has Theravance Biopharma's PP&E (net) changed year-over-year?

Theravance Biopharma's PP&E (net) decreased by 21.2% year-over-year, from $7.03M to $5.54M.

What is the long-term trend for Theravance Biopharma's PP&E (net)?

Over 5 years (2020 to 2025), Theravance Biopharma's PP&E (net) has grown at a -18.5% compound annual growth rate (CAGR), from $16.42M to $5.9M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Theravance Biopharma TBPH PP&E (Net)

PP&E (Net) at other companies

Zevra Therapeutics, Inc.ZVRA

$430K+1.9%

LQD

Liquidia CorporationLQDA

$20.84M+146%

United TherapeuticsUTHR

$1.84B+41.3%

Aurinia PharmaceuticalsAUPH

$1.99M-22.9%

PrecigenPGEN

$13.22M-9.9%

Ultragenyx PharmaceuticalRARE

$239M-8.4%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's PP&E (net)?: Theravance Biopharma (TBPH) reported PP&E (net) of $5.54M in Q1 2026.
How has Theravance Biopharma's PP&E (net) changed year-over-year?: Theravance Biopharma's PP&E (net) decreased by 21.2% year-over-year, from $7.03M to $5.54M.
What is the long-term trend for Theravance Biopharma's PP&E (net)?: Over 5 years (2020 to 2025), Theravance Biopharma's PP&E (net) has grown at a -18.5% compound annual growth rate (CAGR), from $16.42M to $5.9M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.